Effectiveness of the Eko Digital Stethoscope in Capturing Infant ECGs

Description

When a newborn is diagnosed with tachyarrhythmia, they are generally started on medical therapies, most commonly a beta-blocker, while being observed in an inpatient setting. In most academic institutions, current practice is to provide parental teaching on use of a stethoscope to auscultate their child when there is suspicion for distress, in addition to requiring cardiopulmonary resuscitation (CPR) classes. Fortunately, newer technologies have emerged that allow for capture of cardiac rhythm that may provide a buffer between the infant and the emergency room.

Conditions

Tachyarrhythmia

Study Overview

Study Details

Study overview

When a newborn is diagnosed with tachyarrhythmia, they are generally started on medical therapies, most commonly a beta-blocker, while being observed in an inpatient setting. In most academic institutions, current practice is to provide parental teaching on use of a stethoscope to auscultate their child when there is suspicion for distress, in addition to requiring cardiopulmonary resuscitation (CPR) classes. Fortunately, newer technologies have emerged that allow for capture of cardiac rhythm that may provide a buffer between the infant and the emergency room.

Effectiveness of the Eko Digital Stethoscope in Capturing Infant Electrocardiograms

Effectiveness of the Eko Digital Stethoscope in Capturing Infant ECGs

Condition
Tachyarrhythmia
Intervention / Treatment

-

Contacts and Locations

Richmond

Virginia Commonwealth University, Richmond, Virginia, United States, 23298

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Age \<1 year
  • * No previous diagnosis of arrhythmia
  • * Parent/caregiver can provide informed consent
  • * Parent/caregiver can speak and understand simple English
  • * Age ≥ 1 year
  • * Patient has a pacemaker or implantable cardioverter defibrillator (ICD)
  • * Parent/caregiver is unwilling or unable to provide informed consent
  • * Parent/caregiver is unable to speak and understand English

Ages Eligible for Study

to 1 Year

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Virginia Commonwealth University,

Christopher Snyder, PRINCIPAL_INVESTIGATOR, Virginia Commonwealth University

Study Record Dates

2025-12